Home | Welcome to Contract Pharma   
Last Updated Tuesday, May 21 2013
Print RSS Feed

Breaking News

Related Searches: Industry News •
CEL-SCI Takes Delivery of Manufacturing Facility

October 10, 2008
CEL-SCI Corp. has taken delivery of the new manufacturing facility for its lead drug candidate Multikine. This facility, located in the Baltimore area, will produce Multikine for use in CEL-SCI's Phase III trial for first-line therapy of previously u…  Read More »
Patheon Completes ISPS Expansion

October 9, 2008
Patheon has completed its expansion of services using a new Intermediate Scale Processing Suite (ISPS) at its Cincinnati, OH facility. The ISPS provides increased manufacturing capacity, bridging the company's development and commercial scale facilit…  Read More »
Charles River Laboratories

October 9, 2008
Dr. Christophe Berthoux has been named executive vice president, global sales and marketing and chief commercial officer, Charles River Laboratories. In this newly created position, Dr. Berthoux will lead the global realignment of the company's sales…  Read More »
Irvine Pharmaceutical Services

October 9, 2008
Muhammad Asif, Ph.D. has been named director of analytical development, and Paul Maffuid, Ph.D. has been named senior vice president of operations, Irvine Pharmaceutical Services. Dr. Asif has more than 17 years of experience including supporting…  Read More »
Pfizer To Reorganize

October 8, 2008
Pfizer, as part of its strategy to improve growth, plans to reorganize its business units in an effort to better coordinate drug development and commercialization. These changes are part of chief executive officer Jeffrey Kindler's plan to "esta…  Read More »
Bridge Labs Awarded NIDA Tox Contract

October 8, 2008
Bridge Laboratories has been awarded a follow-on contract by the National Institute on Drug Abuse (NIDA). The five-year contract has an estimated value of $4.1 million if all options are exercised. Under the new contract, Bridge will provide toxicolo…  Read More »
Millipore Opens Facility in Ireland

October 8, 2008
Millipore Corp. opened a new membrane casting manufacturing facility in Carrigtwohill, County Cork, Ireland. The 30,000-sq.-ft. facility nearly doubles the company’s membrane production capabilities in Ireland.     “Mill…  Read More »
Alnylam Earns $20 Million Payment from Takeda

October 7, 2008
Alnylam Pharmaceuticals has earned a $20 million technology transfer milestone from Takeda Pharmaceutical Co. Ltd. as part of the companies' strategic alliance formed in May 2008. The payment is related to the transfer of Alnylam’s platform tec…  Read More »
Rituxan Study Meets Endpoint

October 7, 2008
Genentech and Biogen Idec's Phase III study of Rituxan in combination with fludarabine and cyclophosphamide chemotherapy met its primary endpoint of improving progression-free survival (PFS), as assessed by investigators, in patients with previously…  Read More »
Pharmatech To Design Biomanufacturing Facility in China

October 7, 2008
Pharmatech Associates has been chosen by Pacific Biopharma Group (PBG) to provide the design for the first FDA- and EMEA-approved biomanufacturing facility to be built in China, which will represent the first reference document reviewed by the FDA as…  Read More »
Lilly to Acquire ImClone

October 6, 2008
Eli Lilly and Co. and ImClone Systems have entered a definitive merger agreement under which Lilly will acquire ImClone for approximately $6.5 billion in cash. The acquisition of ImClone supports the Lilly's strategy to increase its focus on biopharm…  Read More »
Perrigo Acquires Mexican Manufacturer

October 6, 2008
Perrigo Co. has acquired Laboratorios Diba, S.A. for approximately $25 million in cash. Based in Guadalajara, Mexico, Laboratorios Diba is a store brand manufacturer of OTC and prescription pharmaceuticals, including antibiotics, hormonals and opthal…  Read More »
Alcan Acquires Packaging Facility in India

October 6, 2008
Alcan Global Pharmaceutical Packaging has acquired the Chakan flexible packaging plant from Associated Capsules Ltd. in India. The acquisition expands Alcan's presence in the Indian pharmaceutical market. The Chakan facility has annual sales of $3.…  Read More »
Genentech, GlycArt, Roche Enter Cancer Pact

October 3, 2008
Genentech, Roche, and GlycArt (a company wholly-owned by Roche) have entered into a collaboration that includes a license from GlycArt to Genentech for the joint development and commercialization of GlycArt’s GA101 molecule. The companies will…  Read More »
Amgen Wins Injunction in Mircera Case

October 3, 2008
A federal court granted Amgen a permanent injunction prohibiting Roche Holding AG from selling its Mircera anemia treatment in the U.S., as well as upheld a jury verdict regarding certain patent-infringement claims.     Mircera is…  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: